HAE: Haemonetics EV/EBITDA Multiple
The outlook for Haemonetics Corporation (HAE) is bolstered by the implementation of NexSys PCS systems and growth in plasma collection. The EV/EBITDA ratio in a historical context visualizes the company's valuation relative to earnings, where the 17.47 mark captures this metric. Diversified consumables logistics ensure earnings stability, while patent protection and FDA certifications create insurmountable barriers to entry for new market players.
Summary analytical data breakdowns for haemonetics.com (HAE)
- stock price and consensus target price:
- market capitalization information:
- issuer book value statistics:
- company liabilities and liquidity data:
- financial results and valuation multiples details:
HAE - Net Income|Projected Future Earnings Haemonetics Corporation|HAE - P/E Multiple|Future Price to Earnings Haemonetics Corporation|HAE - Price/Earnings to Growth Ratio|Enterprise Value to EBITDA Ratio Haemonetics Company|HAE - Income before deduction of interest, taxes and amortization|Net earnings per share (EPS TTM) Haemonetics|HAE - Net earnings per one share for the last twelve months|Year-over-year earnings per share growth for the last twelve months haemonetics.com|HAE - Net earnings per share change in current year|Expected earnings per share growth for next year Haemonetics Corporation
Initial company analysis:Haemonetics Corp. HAE
The EV/EBITDA multiple measures the total value of the business, including net debt, relative to operating profit before depreciation and amortization, allowing for an assessment of the asset's payback period regardless of tax impact. An analysis of the EV/EBITDA metric, accounting for debt and amortization for Haemonetics Corporation (HAE), confirms investment stability, as steady demand for blood filtration systems offsets leverage risks in any phase of the economic cycle.
Competitor analysis for Haemonetics Corporation
Dexcom Corp - Enterprise Value to EBITDA Ratio|Enterprise Value to Operating Income Before Depreciation Ratio PEN (Penumbra Medical)|Novanta Inc. - EV/EBITDA Multiple|Total Company Value to Operating Income Before Depreciation Ratio inspiresleep.com INSP|PRCT: EV/EBITDA Multiple|Enterprise Value to EBITDA Ratio CONMED Corp|Enterprise Value to EBITDA Ratio PLSE|INMD: Business Value to Operating Income Before Depreciation|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Picard Medical Inc (PMI)|Enterprise Value to EBITDA Ratio surmodics.com SRDX|EV/EBITDA Multiple SENS (Senseonics Holdings Inc)|NeuroPace Inc (NPCE) - Company Value to EBITDA|Tactile Systems Technology Inc. - EV/EBITDA Multiple|SNWV (SANUWAVE Health Inc) - Enterprise Value to Operating Income Before Depreciation|OM: EV/EBITDA Multiple|ELMD - Total Company Value to Operating Income Before Depreciation Ratio|LNSR (LENSAR) - EV/EBITDA Multiple|Enterprise Value to EBITDA Ratio AVITA Medical Inc. (RCEL)|EV/EBITDA Multiple PROF|EV/EBITDA Multiple bairdmed.com (BDMD)|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization EDAP TMS EDAP|Apyx Medical Corp - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|ICCM: Enterprise Value to EBITDA Ratio|Business Value to Operating Income Before Depreciation LUNG (Pulmonx Corporation)|TELA: EV/EBITDA Multiple|Company Value to EBITDA CytoSorbents Corporation (CTSO)|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Sensus Healthcare, Inc.|ZYXI - Enterprise Value to EBITDA Multiple|Enterprise Value to EBITDA Ratio ECOR (electroCore, Inc.)|EV/EBITDA Multiple vicarioussurgical.com (RBOT)|EV/EBITDA Multiple IINN (Inspira Technologies)|Total Company Value to Operating Income Before Depreciation Ratio SeaStar Medical Holding Corp. (ICU)|IRIX - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Company Value to Operating Income Before Depreciation Ratio INBS|beyondair.net (XAIR) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Enterprise Value to EBITDA Ratio Profusa Inc.|SSKN (STRATA Skin Sciences Inc.) - EV/EBITDA Multiple|Company Value to EBITDA GlucoTrack Inc. GCTK|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization NanoVibronix, Inc. (NAOV)|venusconcept.com - Enterprise Value to Operating Income Before Depreciation|Nuwellis - Enterprise Value to EBITDA Ratio|Enterprise Value to Operating Income Before Depreciation Ratio AEMD (Aethlon Medical Inc)|TransEnterix - EV/EBITDA Multiple|Business Value to Operating Income Before Depreciation AVGR (Avinger Inc)|BSGM: EV/EBITDA Multiple|cutera.com (CUTR) - EV/EBITDA Multiple|KNW (Know Labs) - EV/EBITDA Multiple|Company Value to EBITDA Inari Medical Inc NARI|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Nevro Corporation (NVRO)|Enterprise Value to EBITDA Ratio reshapelifesciences.com RSLS|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Silk Road Medical, Inc SILK
